| Typicality: | 0.523 |
| Saliency: | 0.259 |
| in the same way | 4 | manner |
| at 6 months | 2 | temporal |
| subject → receive → vaccine | 10 |
| subject → receive → the vaccine | 6 |
| subject → receive → the study vaccine | 3 |
| subject → receive → the trial vaccine | 3 |
| negative | neutral | positive |
| 0.184 | 0.749 | 0.067 |
| Raw frequency | 22 |
| Normalized frequency | 0.259 |
| Modifier score | 1.000 |
| Perplexity | 361.732 |